Clinical Trials in North Carolina

Showing 6761-6780 of 15,496 trials

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

NCT04288921

A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx Influenza A/B + RSV Test at Point of Care Testing Sites

Influenza, HumanRespiratory Syncytial Virus Infections

LumiraDx UK Limited2,000 participantsStarted Feb 2020

Birmingham, Alabama, United States • Encinitas, California, United States • Madera, California, United States +17 more locations

TERMINATEDPhase 341 miles

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

NCT03948178

This study provides an opportunity for subjects in the REFALS (3119002; NCT03505021) study to continue treatment with oral levosimendan. The study will also provide more information about long-term safety and effectiveness of oral levosimendan in patients with ALS. This is an open-label study, so that all eligible subjects that complete the double-blind REFALS study (48-weeks of treatment) will have the opportunity to receive oral levosimendan treatment. The primary objective, in addition to continuing treatment for subjects enrolled in the REFALS study, is to evaluate long-term safety of oral levosimendan in ALS patients. Another important objective is to explore long-term effectiveness of oral levosimendan in the treatment of patients with ALS. This study is open only to patients taking part in the REFALS study.

Amyotrophic Lateral Sclerosis

Orion Corporation, Orion Pharma227 participantsStarted Jun 2019

Phoenix, Arizona, United States • La Jolla, California, United States • Orange, California, United States +76 more locations

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Find Trials by Condition in North Carolina

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients

Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

A Study to Test if TEV-48574 is Effective in Relieving Asthma

An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

Transmural Systems Transcaval Closure Device for Transcaval Access Ports During Transcatheter Aortic Valve Replacement

Tele-Coaching Intervention to Improve Treatment Adherence in Cystic Fibrosis

A Prospective Clinical Study of Phenylketonuria (PKU)

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults

A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients